Exscientia Statistics
Total Valuation
Moogene Medi has a market cap or net worth of KRW 20.86 billion.
Market Cap | 20.86B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Moogene Medi has 10.05 million shares outstanding.
Current Share Class | 10.05M |
Shares Outstanding | 10.05M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 29.15% |
Owned by Institutions (%) | n/a |
Float | 4.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1,610.15 |
PB Ratio | 6.35 |
P/TBV Ratio | 7.95 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.82, with a Debt / Equity ratio of 0.09.
Current Ratio | 9.82 |
Quick Ratio | 9.58 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | -0.20 |
Interest Coverage | -76.93 |
Financial Efficiency
Return on equity (ROE) is -50.10% and return on invested capital (ROIC) is -29.06%.
Return on Equity (ROE) | -50.10% |
Return on Assets (ROA) | -28.26% |
Return on Invested Capital (ROIC) | -29.06% |
Return on Capital Employed (ROCE) | -60.71% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.73% in the last 52 weeks. The beta is -0.04, so Moogene Medi's price volatility has been lower than the market average.
Beta (5Y) | -0.04 |
52-Week Price Change | +0.73% |
50-Day Moving Average | 2,103.50 |
200-Day Moving Average | 2,321.20 |
Relative Strength Index (RSI) | 45.82 |
Average Volume (20 Days) | 813 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Moogene Medi had revenue of KRW 12.95 million and -2.08 billion in losses. Loss per share was -332.00.
Revenue | 12.95M |
Gross Profit | 1.22M |
Operating Income | -2.06B |
Pretax Income | -2.08B |
Net Income | -2.08B |
EBITDA | -1.84B |
EBIT | -2.06B |
Loss Per Share | -332.00 |
Balance Sheet
The company has 3.13 billion in cash and 284.65 million in debt, giving a net cash position of 2.85 billion or 283.24 per share.
Cash & Cash Equivalents | 3.13B |
Total Debt | 284.65M |
Net Cash | 2.85B |
Net Cash Per Share | 283.24 |
Equity (Book Value) | 3.29B |
Book Value Per Share | 421.49 |
Working Capital | 2.89B |
Cash Flow
In the last 12 months, operating cash flow was -1.40 billion and capital expenditures -58.98 million, giving a free cash flow of -1.46 billion.
Operating Cash Flow | -1.40B |
Capital Expenditures | -58.98M |
Free Cash Flow | -1.46B |
FCF Per Share | -145.08 |
Margins
Gross Margin | 9.39% |
Operating Margin | -15,919.77% |
Pretax Margin | -16,086.91% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Moogene Medi does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -9.99% |
FCF Yield | -6.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Moogene Medi has an Altman Z-Score of -2.59 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.59 |
Piotroski F-Score | 1 |